Analysts: Emergent BioSolutions Inc (EBS.N)
EBS.N on New York Stock Exchange
17.89USD
1 Aug 2013
17.89USD
1 Aug 2013
Price Change (% chg)
$0.20 (+1.13%)
$0.20 (+1.13%)
Prev Close
$17.69
$17.69
Open
$17.80
$17.80
Day's High
$17.95
$17.95
Day's Low
$17.38
$17.38
Volume
47,464
47,464
Avg. Vol
50,780
50,780
52-wk High
$18.25
$18.25
52-wk Low
$12.50
$12.50
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | 0.26 | December | 2 Aug 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 2 | 2 | 3 | 3 |
| (2) OUTPERFORM | 3 | 3 | 2 | 2 |
| (3) HOLD | 0 | 0 | 0 | 0 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 1.60 | 1.60 | 1.40 | 1.40 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 5 | 81.14 | 86.18 | 76.22 | 85.50 |
| Quarter Ending Dec-13 | 5 | 98.83 | 105.50 | 88.68 | 85.50 |
| Year Ending Dec-13 | 5 | 298.80 | 305.10 | 293.95 | 317.14 |
| Year Ending Dec-14 | 5 | 323.02 | 346.90 | 296.49 | 334.61 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 5 | 0.26 | 0.29 | 0.23 | 0.38 |
| Quarter Ending Dec-13 | 5 | 0.49 | 0.62 | 0.33 | 0.38 |
| Year Ending Dec-13 | 4 | 0.79 | 0.86 | 0.75 | 0.97 |
| Year Ending Dec-14 | 5 | 0.95 | 1.12 | 0.72 | 1.20 |
| LT Growth Rate (%) | 1 | 10.00 | 10.00 | 10.00 | 32.00 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-13 | 46.17 | 43.10 | 3.07 | 6.65 |
| Quarter Ending Dec-12 | 95.09 | 94.61 | 0.49 | 0.51 |
| Quarter Ending Sep-12 | 68.49 | 66.59 | 1.90 | 2.77 |
| Quarter Ending Jun-12 | 76.82 | 70.38 | 6.44 | 8.38 |
| Quarter Ending Mar-12 | 47.32 | 50.31 | 2.99 | 6.32 |
| Earnings (per share) | ||||
| Quarter Ending Mar-13 | -0.14 | -0.22 | 0.08 | -52.78 |
| Quarter Ending Dec-12 | 0.45 | 0.44 | 0.01 | 1.68 |
| Quarter Ending Sep-12 | 0.14 | 0.18 | 0.04 | 28.57 |
| Quarter Ending Jun-12 | 0.23 | 0.21 | 0.02 | 8.70 |
| Quarter Ending Mar-12 | -0.15 | -0.02 | 0.13 | -86.30 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 81.14 | 81.14 | 81.14 | 81.14 | 85.50 |
| Quarter Ending Dec-13 | 98.83 | 98.83 | 98.83 | 98.83 | 85.50 |
| Year Ending Dec-13 | 298.80 | 298.80 | 298.80 | 298.80 | 317.14 |
| Year Ending Dec-14 | 323.02 | 323.02 | 323.02 | 323.02 | 334.61 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 0.26 | 0.26 | 0.26 | 0.26 | 0.38 |
| Quarter Ending Dec-13 | 0.49 | 0.49 | 0.49 | 0.49 | 0.38 |
| Quarter Ending Dec-13 | 0.79 | 0.79 | 0.79 | 0.79 | 0.97 |
| Quarter Ending Dec-14 | 0.95 | 0.95 | 0.95 | 0.95 | 1.20 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-14 | 0 | 0 | 0 | 0 |
| Earnings | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-14 | 0 | 0 | 0 | 0 |
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: MacroRisk Analytics/EconomicInvestor
|
$15.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Earnings vs.
Estimates